JP2020022459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020022459A5 JP2020022459A5 JP2019169775A JP2019169775A JP2020022459A5 JP 2020022459 A5 JP2020022459 A5 JP 2020022459A5 JP 2019169775 A JP2019169775 A JP 2019169775A JP 2019169775 A JP2019169775 A JP 2019169775A JP 2020022459 A5 JP2020022459 A5 JP 2020022459A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- adenovirus
- vector
- transgene
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000701161 unidentified adenovirus Species 0.000 claims 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108700019146 Transgenes Proteins 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161543661P | 2011-10-05 | 2011-10-05 | |
| US61/543,661 | 2011-10-05 | ||
| JP2018137237A JP6970647B2 (ja) | 2011-10-05 | 2018-07-20 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018137237A Division JP6970647B2 (ja) | 2011-10-05 | 2018-07-20 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020022459A JP2020022459A (ja) | 2020-02-13 |
| JP2020022459A5 true JP2020022459A5 (enExample) | 2020-03-26 |
| JP7394285B2 JP7394285B2 (ja) | 2023-12-08 |
Family
ID=47045181
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534785A Active JP6757121B2 (ja) | 2011-10-05 | 2012-10-05 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
| JP2018137237A Active JP6970647B2 (ja) | 2011-10-05 | 2018-07-20 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
| JP2019169775A Active JP7394285B2 (ja) | 2011-10-05 | 2019-09-18 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534785A Active JP6757121B2 (ja) | 2011-10-05 | 2012-10-05 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
| JP2018137237A Active JP6970647B2 (ja) | 2011-10-05 | 2018-07-20 | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9617560B2 (enExample) |
| EP (1) | EP2764014B1 (enExample) |
| JP (3) | JP6757121B2 (enExample) |
| CN (2) | CN103987726B (enExample) |
| BR (1) | BR112014008284A2 (enExample) |
| CA (1) | CA2851251C (enExample) |
| WO (1) | WO2013052832A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6757119B2 (ja) | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| EP2764013B1 (en) | 2011-10-05 | 2022-01-26 | GenVec, Inc. | Adenoviral vectors and methods of use |
| CN103987726B (zh) * | 2011-10-05 | 2017-10-03 | 金维克有限公司 | 猴(大猩猩)腺病毒或腺病毒载体及其使用方法 |
| US9676824B2 (en) * | 2012-05-29 | 2017-06-13 | Genvec, Inc. | Herpes simplex virus vaccine |
| GB2549809C (en) | 2016-06-23 | 2022-11-30 | Univ Oxford Innovation Ltd | Vector |
| WO2018037045A1 (en) | 2016-08-23 | 2018-03-01 | Glaxosmithkline Biologicals Sa | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
| BE1024774B1 (fr) | 2016-09-29 | 2018-07-02 | Glaxosmithkline Biologicals Sa | Compositions et procedes de traitement |
| GB201616904D0 (en) | 2016-10-05 | 2016-11-16 | Glaxosmithkline Biologicals Sa | Vaccine |
| WO2018069316A2 (en) | 2016-10-10 | 2018-04-19 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
| EP3551644B1 (en) | 2016-12-09 | 2023-08-16 | GlaxoSmithKline Biologicals SA | Chimpanzee adenovirus constructs with lyssavirus antigens |
| GB201701239D0 (en) | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
| US11649467B2 (en) | 2017-07-21 | 2023-05-16 | Glaxosmithkline Biologicals Sa | Chikungunya virus antigen constructs |
| WO2019086466A1 (en) * | 2017-10-31 | 2019-05-09 | Janssen Vaccines & Prevention B.V. | Adenovirus and uses thereof |
| CN112088015A (zh) | 2018-03-06 | 2020-12-15 | 普莱西根股份有限公司 | 人乳头瘤病毒疫苗及其用途 |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| JP7640538B2 (ja) | 2019-10-08 | 2025-03-05 | トラスティーズ オブ ボストン カレッジ | 複数の異なる非天然アミノ酸を含有するタンパク質、並びにそのようなタンパク質の製造方法及び使用方法 |
| EP4061405A1 (en) | 2019-11-18 | 2022-09-28 | Janssen Biotech, Inc. | Vaccines based on mutant calr and jak2 and their uses |
| US20230085724A1 (en) | 2020-03-05 | 2023-03-23 | Neotx Therapeutics Ltd. | Methods and compositions for treating cancer with immune cells |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| CN112220921B (zh) * | 2020-08-25 | 2022-08-16 | 北京交通大学 | 一种针对呼吸道合胞病毒感染的组合疫苗 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
| ATE399873T1 (de) | 1993-07-13 | 2008-07-15 | Centelion | Defekte adenovirus-vektoren und deren verwendung in der gentherapie |
| WO1995016772A1 (en) | 1993-12-14 | 1995-06-22 | Cornell Research Foundation, Inc. | Adenovirus gene expression system |
| US5851806A (en) | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
| CA2192442C (en) | 1994-06-10 | 2007-09-25 | Imre Kovesdi | Complementary adenoviral vector systems and cell lines |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| US5994128A (en) | 1995-06-15 | 1999-11-30 | Introgene B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| US5837511A (en) | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
| EP0885012A4 (en) | 1996-01-29 | 2001-09-05 | Univ Georgetown | MALARIA Vaccine, which also contains an MSA1 peptide |
| US6113913A (en) | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| AU2001234981A1 (en) | 2000-02-09 | 2001-08-20 | Genvec, Inc. | Adenoviral capsid containing chimeric protein ix |
| US6821519B2 (en) | 2000-06-29 | 2004-11-23 | Corixa Corporation | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| US20040136963A1 (en) * | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| WO2003020879A2 (en) | 2001-07-23 | 2003-03-13 | Genvec, Inc. | Cells and methods for propagating adenoviral vectors |
| US6677156B2 (en) | 2001-07-23 | 2004-01-13 | Genvec, Inc. | Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| US6682929B2 (en) | 2001-07-23 | 2004-01-27 | Genvec, Inc. | Adenovector complementing cells |
| CA2454992A1 (en) | 2001-09-13 | 2003-03-20 | Genvec, Inc. | Adenoviral vector and related system and methods of making and use |
| WO2005075506A1 (en) | 2004-01-09 | 2005-08-18 | The Scripps Research Institute | Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors |
| ATE516343T1 (de) | 2004-12-13 | 2011-07-15 | Canji Inc | Zellinien zur produktion von replikationsdefektem adenovirus |
| DE102005006388A1 (de) * | 2005-02-11 | 2006-08-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Replikationsdefiziente RNA-Viren als Impfstoffe |
| WO2007027860A2 (en) | 2005-08-31 | 2007-03-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccines |
| WO2007073513A2 (en) | 2005-11-10 | 2007-06-28 | Genvec, Inc. | Method for propagating adenoviral vectors encoding inhibitory gene products |
| JP5872755B2 (ja) | 2006-07-20 | 2016-03-01 | バイカル インコーポレイテッド | 抗ｈｓｖ−２ワクチン接種のための組成物および方法 |
| US8940290B2 (en) | 2008-10-31 | 2015-01-27 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof |
| SG2014007959A (en) | 2009-02-02 | 2014-03-28 | Okair S Ag | Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof |
| CN102549152B (zh) | 2009-07-31 | 2015-11-25 | 帕克斯瓦克斯股份有限公司 | 基于腺病毒的载体 |
| BR112012010824A2 (pt) | 2009-11-09 | 2018-03-06 | Genvec Inc | adenovirus simios e métodos de uso |
| WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
| WO2012021730A2 (en) | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
| EP2764013B1 (en) * | 2011-10-05 | 2022-01-26 | GenVec, Inc. | Adenoviral vectors and methods of use |
| CN103987726B (zh) * | 2011-10-05 | 2017-10-03 | 金维克有限公司 | 猴(大猩猩)腺病毒或腺病毒载体及其使用方法 |
| JP6757119B2 (ja) | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| EP2764011B1 (en) * | 2011-10-05 | 2021-04-07 | GenVec, Inc. | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| WO2013116591A1 (en) * | 2012-02-02 | 2013-08-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccine |
| US9676824B2 (en) | 2012-05-29 | 2017-06-13 | Genvec, Inc. | Herpes simplex virus vaccine |
-
2012
- 2012-10-05 CN CN201280059662.5A patent/CN103987726B/zh active Active
- 2012-10-05 WO PCT/US2012/059006 patent/WO2013052832A2/en not_active Ceased
- 2012-10-05 CN CN201710795518.2A patent/CN107574154A/zh active Pending
- 2012-10-05 BR BR112014008284-7A patent/BR112014008284A2/pt not_active Application Discontinuation
- 2012-10-05 CA CA2851251A patent/CA2851251C/en active Active
- 2012-10-05 JP JP2014534785A patent/JP6757121B2/ja active Active
- 2012-10-05 EP EP12775113.9A patent/EP2764014B1/en active Active
- 2012-10-05 US US14/349,470 patent/US9617560B2/en active Active
-
2017
- 2017-04-10 US US15/482,991 patent/US10059962B2/en active Active
-
2018
- 2018-07-20 JP JP2018137237A patent/JP6970647B2/ja active Active
- 2018-07-24 US US16/043,501 patent/US10787682B2/en active Active
-
2019
- 2019-09-18 JP JP2019169775A patent/JP7394285B2/ja active Active
-
2020
- 2020-08-25 US US17/002,064 patent/US11359214B2/en active Active